Integrin Beta1 Market, By Type (AXT-108, C-16Y, CLT-28643, SAL-021 and Others), By Indication (Genetic Disorder, Dermatology, Cardiovascular and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

The world market for Integrin Beta 1 is divided into five regions: Latin America, North America, Europe, Asia Pacific, and the Middle East and Africa. North America's developed and well-organized healthcare system is expected to make it the market leader during the forecast period. This area is primarily dedicated to cancer research. North America is home to essential players as well. The United States and Canada have a large patient population, which further fuels market expansion. For example, according to a 2018 report from the World Cancer Research Fund International, there are 352.2 cases of cancer per 100,000 people in the United States. According to that same report, 334 cases of cancer are reported for every 100,000 people in Canada.